$GNVR Cashflow Statement | Understand Stock

$GNVR

$0.69 -$0.01 (1.43%) Close

$GNVR Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In USD, except per-share amounts

	FY2025 12 months to Sep 30, 2025	FY2024 12 months to Sep 30, 2024	FY2023 12 months to Sep 30, 2023	FY2022 9 months to Sep 30, 2022	FY2021 12 months to Sep 30, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss
Operating expenses paid by shareholder
Operating expenses paid by Genvor
Accounts payable
Accrued expenses

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense
Interest expense capitalized into notes payable
Late fee capitalized into notes payable
Loss on Agromed acquisition failure
Depreciation expense
Late fee related to notes payable
Common stock issued for interest expense
Effects of the elimination of the beneficial conversion feature
Beneficial conversion feature
(Gain) loss on debt settlement
Gain on settlement of accounts payable with common stock
Amortization of debt discount
Loss on settlement of liabilities
Stock-based compensation and service expense
Beneficial conversion feature amortization
Non-cash other expense
Gain on extinguishment of notes payable
Loss on disposal of property and equipment
Prepaid expense
Prepaid costs for reverse capitalization
Other current assets
Receivables from related parties
Interest payable
Accrued interest
Accrued professional fees
Accrued research and development fees
Accrued payroll liability and compensation
Accounts payable and accrued expenses
Accrued compensation and related expenses
USDA CRADA liability
Due to related party
NET CASH USED IN OPERATING ACTIVITIES
Cash flows from investing activities
Proceeds from issuance of convertible debt and warrants
Proceeds from notes payable
Payments of notes payable
Payments of receivable from related parties
Advances from related parties
Repayments to related parties
Proceeds from sale of common stock
Proceeds from common stock warrant exercises
NET CASH PROVIDED BY FINANCING ACTIVITIES
Net change in cash
Cash, beginning of the year
Cash, end of the year
Net increase (decrease) in cash
NET INCREASE ( DECREASE) IN CASH
CASH - beginning of year
CASH - end of year
Cash paid for interest
Cash paid for taxes
NON-CASH OPERATING AND FINANCING ACTIVITIES:
Right of use, lease asset and liability
Issuance of common stock for debt conversion
Discount on notes payable
Conversion of note payable into common stock
Note payable settled with common stock
Conversion of debt for common stock subscribed
Conversion of liabilities into common stock
Conversion of notes payable into warrants
Issuance of common stock for debt settlement
Fundraising services
Prepaid costs for reverse capitalization recognized in additional paid-in capital
Allocated value of warrants related to convertible debt
Late fee capitalized into notes payable
Retrospective adoption of ASU 2020-06
Liabilities issued in exchange for stock in settlement
Accrued compensation settled with common stock
Accrued compensation converted to common stock
Accounts payable settled with common stock
Common stock issued from prior year settlements

Comments